|
Oncolab raises some very important red flags. The company makes the AMAS test, an early warning blood screening test for cancer. The test detects abnormal levels of anti-malignin antibody which may indicate the presence of tumors. It is the first antibody that can be directly related to the survival of cancer patients and can be easily detected even before malignin reaches a detectable level. The test is shipped for free and is administered by doctors, then sent to Oncolab to process the results (for a fee). CEO Samuel Bogoch founded Oncolab shortly after he discovered the technology for detecting anti-malignin antibodies in the 1960s.
|
| | | Contact Information | |
Address: |
36 The Fenway
Boston, MA 02215-4006
| | Phone: | 617-536-0850 | | Fax: | 617-536-0657 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 0.50 M | | Employees (2008): | 8 |
|
|
Key People
| | • |
CEO:
Samuel Bogoch
| | • |
President, Secretary, and Treasurer:
Elenore Bogoch
|
|
|
